Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 11.95
-0.45 (-3.63%)
Jul 29, 2026, 1:36 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 6.97 billion as of July 29, 2026. Its market cap has decreased by -22.44% in one year.
Market Cap
6.97B
Enterprise Value
3.42B
Revenue
185.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
11.95
ChartMarket Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 6.97B, a decrease of -69.62%. That is a compound annual growth rate of -32.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 6.97B | -22.05% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tanvex BioPharma | 10.24B |
| PharmaEngine | 9.47B |
| AP Biosciences | 9.16B |
| Locus Cell | 8.02B |
| Adimmune | 7.19B |
| Savior Lifetec | 6.40B |
| Sinphar Pharmaceutical | 6.00B |
| TaiGen Biopharmaceuticals Holdings | 5.91B |